EA
XRAY icon

Euclid Advisors’s Dentsply Sirona XRAY Stock Holding History

Euclid Advisors’s Portfolio XRAY Stock Details XRAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-342,334
Closed -$21.2M – 470
2016
Q2 		$21.2M Sell
342,334
-94,580
-22% -$5.82M 0.92% 10
2016
Q1 		$26.9M Buy
436,914
+72,027
+20% +$4.24M 1.02% 10
2015
Q4 		$22.2M Buy
+364,887
New +$21.7M 0.68% 34
2015
Q3 		– Sell
-6,222
Closed -$321K – 445
2015
Q2 		$321K Sell
6,222
-44,928
-88% -$2.33M 0.01% 433
2015
Q1 		$2.6M Buy
+51,150
New +$2.64M 0.05% 259
2014
Q4 		– Sell
-71,070
Closed -$3.24M – 508
2014
Q3 		$3.24M Buy
71,070
+3,660
+5% +$172K 0.02% 442
2014
Q2 		$3.19M Sell
67,410
-10,647
-14% -$495K 0.02% 438
2014
Q1 		$3.59M Buy
78,057
+21,240
+37% +$983K 0.03% 361
2013
Q4 		$2.75M Sell
56,817
-3,320
-6% -$155K 0.02% 467
2013
Q3 		$2.61M Buy
60,137
+12,292
+26% +$524K 0.03% 429
2013
Q2 		$1.96M Buy
+47,845
New +$1.99M 0.02% 442

Other funds holding XRAY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Euclid Advisors's XRAY Position: Q3 2016 in Review

Euclid Advisors sold out of Dentsply Sirona (XRAY) in Q3 2016, closing a stake of 342,334 shares — an estimated $21.2M sold.

Euclid Advisors first reported a position in XRAY in Q2 2013 and held it in 11 quarters. The position peaked at $26.9M in Q1 2016. 548 funds tracked by Wall St. Rank hold XRAY as of Q3 2016.

  • Euclid Advisors reported no remaining Dentsply Sirona position as of Q3 2016 after selling out during the quarter.
  • Euclid Advisors sold 342,334 Dentsply Sirona shares in Q3 2016, an estimated $21.2M.
  • Euclid Advisors first reported a position in Dentsply Sirona in Q2 2013 and held it in 11 quarters.
  • Euclid Advisors's Dentsply Sirona position peaked at $26.9M in Q1 2016.
  • 548 funds tracked by Wall St. Rank held Dentsply Sirona as of Q3 2016.

Based on Euclid Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.